CD37 is expressed on multiple tumor subtypes, including B cell NHL, CLL, Waldenstrom’s macroglobulinemia, T-ALL, PTCL (reported 82 % positive for CD37), and AML [28–30]. This evidence concerns the gene CD37 and mature T-cell and NK-cell non-Hodgkin lymphoma.